City

New York (1)

Seoul (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 4 (1)

Sponsor

Kim's Eye Hospital (1)

Manhattan Eye, Ear & Throat Hospital (1)

Collaborator

Bayer (1)

Genentech, Inc. (1)

Intervention

aflibercept injection (1)

ranibizumab injection (0.5 mg) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

retinal angiomatous proliferation

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Retinal Angiomatous Proliferation Trial in Seoul (Aflibercept Injection)

Recruiting

Retinal Angiomatous Proliferation

Aflibercept Injection

Seoul, Korea, Republic of

Jae Hui Kim

Feb 20, 2021

Coats' Disease, Idiopathic Retinal Telangiectasia, Retinal Angiomatous Proliferation Trial in New York (ranibizumab injection

Completed

Coats' Disease
+9 more

ranibizumab injection (0.5 mg)

New York, New York
+1 more

Oct 24, 2012